These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2115296)

  • 1. Impairment of glucose tolerance: mechanism of action and impact on the cardiovascular system.
    Beck-Nielsen H; Hother Nielsen O; Damsbo P; Vaag A; Handberg A; Henriksen JE
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):292-5. PubMed ID: 2115296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins.
    Crook D; Godsland IF; Wynn V
    Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1612-20. PubMed ID: 3287933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interrelationships among insulin's antilipolytic and glucoregulatory effects and plasma triglycerides in nondiabetic and diabetic patients with endogenous hypertriglyceridemia.
    Yki-Järvinen H; Taskinen MR
    Diabetes; 1988 Sep; 37(9):1271-8. PubMed ID: 3044892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical aspects of the relationship between oral contraceptives, abnormalities in carbohydrate metabolism, and the development of cardiovascular disease.
    Gaspard UJ; Lefebvre PJ
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):334-43. PubMed ID: 2196805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance in skeletal muscles in patients with NIDDM.
    Beck-Nielsen H; Vaag A; Damsbo P; Handberg A; Nielsen OH; Henriksen JE; Thye-Rønn P
    Diabetes Care; 1992 Mar; 15(3):418-29. PubMed ID: 1559409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus.
    Groop LC; Saloranta C; Shank M; Bonadonna RC; Ferrannini E; DeFronzo RA
    J Clin Endocrinol Metab; 1991 Jan; 72(1):96-107. PubMed ID: 1986032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic impact of oral contraceptives.
    Krauss RM; Burkman RT
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1177-84. PubMed ID: 1415443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired insulin-stimulated nonoxidative glucose metabolism in pancreas-kidney transplant recipients. Dose-response effects of insulin on glucose turnover.
    Christiansen E; Vestergaard H; Tibell A; Hother-Nielsen O; Holst JJ; Pedersen O; Madsbad S
    Diabetes; 1996 Sep; 45(9):1267-75. PubMed ID: 8772733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose oral contraceptives and carbohydrate metabolism.
    Godsland IF; Crook D; Wynn V
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):348-53. PubMed ID: 2196807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study.
    Patel DA; Srinivasan SR; Xu JH; Chen W; Berenson GS
    Metabolism; 2006 Nov; 55(11):1551-7. PubMed ID: 17046560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-administration of etomoxir and RU-486 mitigates insulin resistance in hepatic and muscular tissues of STZ-induced diabetic rats.
    Bitar MS
    Horm Metab Res; 2001 Oct; 33(10):577-84. PubMed ID: 11607876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the metabolic effects of steroidal contraceptives and their relationship to cardiovascular disease risk.
    Godsland IF; Crook D
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1528-36. PubMed ID: 8178902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats.
    Henriksen EJ; Kinnick TR; Teachey MK; O'Keefe MP; Ring D; Johnson KW; Harrison SD
    Am J Physiol Endocrinol Metab; 2003 May; 284(5):E892-900. PubMed ID: 12517738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperglycemia markedly enhances skeletal muscle glycogen synthase activity in diabetic, but not in normal conscious rats.
    Farrace S; Rossetti L
    Diabetes; 1992 Nov; 41(11):1453-63. PubMed ID: 1397721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease.
    Yip J; Facchini FS; Reaven GM
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2773-6. PubMed ID: 9709945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.
    Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH
    Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.